Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052

Objective: Data comparing hepatitis B virus (HBV) infection in HIV-infected [HIV(+)], and HIV-uninfected [HIV(−)] individuals recruited into the same study are limited. HBV infection status and chronic hepatitis B (cHB) were characterized in a multinational clinical trial: HIV Prevention Trials Network (HPTN 052). Method: HBV infection status at enrollment was compared between HIV(+) (N = 1241) and HIV(−) (N = 1232) from 7 HBV-endemic countries. Hepatitis B e antigen and plasma HBV DNA were determined in cHB. Median CD4, median plasma HIV RNA, and prevalence of transaminase elevation were compared in HIV(+) with and without cHB. Significance was assessed with &khgr;2, Fisher exact, and median tests. Results: Among all participants, 33.6% had HBV exposure without cHB (8.9% isolated HBV core antibody, “HBcAb”; 24.7% HBcAb and anti-HB surface antibody positive, “recovered”), 4.3% had cHB, 8.9% were vaccinated, and 53.5% were uninfected. Data were similar among HIV(+) and HIV(−) except for isolated HBcAb, which was more prevalent in HIV(+) than HIV(−) [10.1% vs. 7.7%, P = 0.046]. Median HBV DNA trended higher in HIV(+) than in HIV(−). In HIV(+) with cHB versus those without cHB, transaminase elevations were more prevalent (alanine aminotransferase ⩽ grade 2, 12% vs. 5.2%, P = 0.037; aspartate aminotransferase ⩽ grade 2, 26% vs. 6.0%, P < 0.001), CD4 trended lower, and HIV RNA was similar. Conclusions: HBV infection status did not differ by HIV infection status. HIV co-infection was associated with isolated HBcAb and a trend of increased HBV DNA. In HIV, cHB was associated with mild transaminase elevations and a trend toward lower CD4.

[1]  E. Valore,et al.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload. , 2017, Journal of hepatology.

[2]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[3]  B. Chi,et al.  Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  B. Chi,et al.  Association between hepatitis B co‐infection and elevated liver stiffness among HIV‐infected adults in Lusaka, Zambia , 2016, Tropical medicine & international health : TM & IH.

[5]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[6]  J. Phair,et al.  Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection , 2016, Journal of acquired immune deficiency syndromes.

[7]  N. Budambula,et al.  Erratum to: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya , 2015, BMC Infectious Diseases.

[8]  R. Weber,et al.  HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons , 2015, BMC Gastroenterology.

[9]  R. Kahn,et al.  Prevalence of HIV and Hepatitis B Virus Co-Infection in Sub-Saharan Africa and the Potential Impact and Program Feasibility of Hepatitis B Surface Antigen Screening in Resource-Limited Settings , 2015, Journal of acquired immune deficiency syndromes.

[10]  M. Chayakulkeeree,et al.  Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients. , 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[11]  W. Preiser,et al.  The HIV/HBV co-infected patient: Time for proactive management. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[12]  P. Klenerman,et al.  Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  C. Spada,et al.  The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.

[14]  Ajit Kumar,et al.  Hepatitis B and/or C co-infection in HIV infected patients: A study in a tertiary care centre from south India , 2013, The Indian journal of medical research.

[15]  B. Berkhout,et al.  High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011 , 2013, BMC Infectious Diseases.

[16]  M. Tsai,et al.  Hepatitis B virus (HBV) coinfection accelerates immunologic progression in patients with primary HIV infection in an area of hyperendemicity for HBV infection. , 2013, The Journal of infectious diseases.

[17]  S. Chakrabarti,et al.  Characterization of Treatment-Naive HIV/HBV Co-Infected Patients Attending ART Clinic of a Tertiary Healthcare Centre in Eastern India , 2013, PloS one.

[18]  P. Peters,et al.  An Evaluation of Hepatitis B Virus Diagnostic Methods and Responses to Antiretroviral Therapy among HIV-Infected Women in Thailand , 2013, Journal of the International Association of Providers of AIDS Care.

[19]  S. Nanta,et al.  Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  C. Thio,et al.  Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Kulkarni,et al.  Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort , 2013, AIDS.

[22]  S. Eholie,et al.  Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. , 2012, World journal of hepatology.

[23]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[24]  C. Thio,et al.  HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. , 2012, The Journal of infectious diseases.

[25]  Helen M. Chun,et al.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. , 2012, The Journal of infectious diseases.

[26]  William M. Lee,et al.  Hepatitis B virus genotype G: Prevalence and impact in patients co‐infected with human immunodeficiency virus , 2011, Journal of medical virology.

[27]  J. Kostman,et al.  Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients , 2010, BMC infectious diseases.

[28]  Tai‐Jui Chen,et al.  Risk Factors of Isolated Antibody Against Core Antigen of Hepatitis B Virus: Association With HIV Infection and Age but not Hepatitis C Virus Infection , 2010, Journal of acquired immune deficiency syndromes.

[29]  Michael Y. Lin,et al.  Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  C. Thio,et al.  Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. , 2007, The Lancet. Infectious diseases.

[31]  M. Young,et al.  Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. , 2007, The Journal of infectious diseases.

[32]  B. McMahon,et al.  Chronic hepatitis B. , 2002, The New England journal of medicine.

[33]  P. Alm Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India , 2007 .

[34]  A. Lok,et al.  Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.

[35]  A. Vibhagool,et al.  Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[36]  S. Schaefer,et al.  Hepatitis B virus genotypes: comparison of genotyping methods , 2004, Reviews in medical virology.

[37]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[38]  M. L. Rodriguez-Mendez,et al.  Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection , 2000, American Journal of Gastroenterology.

[39]  M. Loriot,et al.  Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.

[40]  Bernice W. Polemis Nonparametric Statistics for the Behavioral Sciences , 1959 .